iBio, Inc. — Director's Dealing 2014

Jan 31, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (ibio)
CIK: 0001420720
Period of Report: 2014-01-30

Reporting Person: DESANTIS CARL (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-30	Common Stock	S	19160	$0.55	Disposed	6004203	Indirect
2014-01-31	Common Stock	S	54889	$0.56	Disposed	5949314	Indirect

Footnotes

F1: Includes (i) 6,125 shares of common stock owned directly by the reporting person, (ii) 1,266,706 shares of common stock held by Integrated BioPharma, Inc. of which the reporting person is a controlling person, (iii) 1,530,563 shares of common stock held by CD Financial, LLC, and (iv) 3,145,920 shares of common stock held by DeSantis Revocable Trust (after accounting for the disposition of the 74,049 shares of common stock that are the subject of this report).